Desktop Site
|
28 Mar 24 | 14:00
|
Open
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Watch List
Get Quote
Notices
|
S&P
BSE SENSEX
73,998.25
+1,001.94
+1.37 %
Corporate Announcement
Security Code
500420
Company
TORRENT PHARMACEUTICALS LTD.
Exchange Received Time
23/10/2019 17:11:14
Exchange Disseminated Time
23/10/2019 17:11:21
Time Taken
00:00:07
Submission / Intimation Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements), 2015, ('Listing Regulations') |
10/23/2019 5:11:14 PM
We would like to inform that the Board has at its meeting held today approved, inter-alia, the Audited Standalone Financial Results along with audit report thereon and Unaudited Consolidated Financial Results along with the limited review report of the Company for the quarter and half year ended on 30th September, 2019. The said financial results are enclosed herewith.
In terms of Regulation 47 of the Listing Regulations, the Company will publish an extract of Unaudited Consolidated Financial Results for the quarter and half year ended on 30th September, 2019. Both Standalone and Consolidated Financial Results will be available at Company's website www.torrentpharma.com.
A Press Release on Financial Results which is being submitted to the media is also enclosed herewith.
Attachment
<< Back
Recently Viewed